1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Swedish national guidelines on urothelial carcinoma : 2024 update on advanced and metastatic disease
- Contribution to journal › Article
-
Mark
Peritoneal recurrence following nephrectomy for localized renal cancer : A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study–UroCCR 124)
(2025) In Urologic Oncology: Seminars and Original Investigations
- Contribution to journal › Article
- 2024
-
Mark
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
- Contribution to journal › Article
-
Mark
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort : The Swedish Norwegian Testicular Cancer Group Experience
- Contribution to journal › Article
- 2023
-
Mark
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups
- Contribution to journal › Article
- 2019
-
Mark
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study) : Protocol for a multicenter phase II open label study
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma
- Contribution to journal › Article
-
Mark
Improved oncological treatment of anal cancer
- Thesis › Doctoral thesis (compilation)
- 2018
-
Mark
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma
- Contribution to journal › Debate/Note/Editorial
- 2010
-
Mark
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
- Contribution to journal › Article
